Trillium and Biogen Idec Enter Into Global License Agreement
Advertisement
Trillium Therapeutics Inc. (TTI) announced that it has entered into a definitive license agreement with Biogen Idec, granting the latter exclusive worldwide rights to one of Trillium's development programs.
Under the terms of the agreement, TTI will receive an upfront payment and is eligible to receive milestone payments based on achievements of specified clinical, regulatory and commercial accomplishments. TTI will also receive royalties on global product sales. No other financial terms were disclosed. Biogen Idec will be solely responsible for clinical development, regulatory approvals, manufacturing and commercialization.
"Trillium's strong immunology foundation and its close connection toToronto'sworld class immunology research community, has allowed it to build a suite of exciting biologies opportunities in the immunoregulatory field", said Dr. Michael Moore, Trillium's Chairman. "We look forward to concluding additional partnerships later in the year, particularly around our non-core assets."
Most read news
Organizations
Other news from the department business & finance
Get the life science industry in your inbox
By submitting this form you agree that LUMITOS AG will send you the newsletter(s) selected above by email. Your data will not be passed on to third parties. Your data will be stored and processed in accordance with our data protection regulations. LUMITOS may contact you by email for the purpose of advertising or market and opinion surveys. You can revoke your consent at any time without giving reasons to LUMITOS AG, Ernst-Augustin-Str. 2, 12489 Berlin, Germany or by e-mail at revoke@lumitos.com with effect for the future. In addition, each email contains a link to unsubscribe from the corresponding newsletter.
Most read news
More news from our other portals
Last viewed contents
How metastasizing cancer cells enter organs
Bacteria contribute to the modulation of animal behaviour - Research team uses the example of the freshwater polyp Hydra to show how nerve cells and microorganisms cooperate to control the animals' feeding behaviour
AI with infrared imaging enables precise colon cancer diagnostics - Artificial intelligence and infrared imaging automatically classify tumours and are faster than previous methods
Study shows how gene controls common pathways in cancer progression